(Q39799629)

English

IRAK1-independent pathways required for the interleukin-1-stimulated activation of the Tpl2 catalytic subunit and its dissociation from ABIN2.

scientific article published on 23 October 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

IRAK1-independent pathways required for the interleukin-1-stimulated activation of the Tpl2 catalytic subunit and its dissociation from ABIN2. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

author name string

Hosea Handoyo

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Margaret J Stafford

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Eamon McManus

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Dionissios Baltzis

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Mark Peggie

5

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Philip Cohen

6

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

language of work or name

0 references

publication date

23 October 2009

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

Biochemical Journal

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

424

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

109-118

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091271

21 January 2018

Genetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor-induced Crohn's-like inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091271

21 January 2018

Role of mitogen-activated protein kinase cascades in mediating lipopolysaccharide-stimulated induction of cyclooxygenase-2 and IL-1 beta in RAW264 macrophages

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091271

21 January 2018

IL-1beta-stimulated activation of ERK1/2 and p38alpha MAPK mediates the transcriptional up-regulation of IL-6, IL-8 and GRO-alpha in HeLa cells.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091271

21 January 2018

Tpl2 transduces CD40 and TNF signals that activate ERK and regulates IgE induction by CD40.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091271

21 January 2018

IkappaB kinase is an essential component of the Tpl2 signaling pathway

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091271

21 January 2018

TRAF6 and Src kinase activity regulates Cot activation by IL-1.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091271

21 January 2018

Pharmacologic inhibition of tpl2 blocks inflammatory responses in primary human monocytes, synoviocytes, and blood.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091271

21 January 2018

ABIN-2 forms a ternary complex with TPL-2 and NF-kappa B1 p105 and is essential for TPL-2 protein stability

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091271

21 January 2018

NF-kappaB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the Tpl2 kinase

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091271

21 January 2018

Lipopolysaccharide activation of the TPL-2/MEK/extracellular signal-regulated kinase mitogen-activated protein kinase cascade is regulated by IkappaB kinase-induced proteolysis of NF-kappaB1 p105.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091271

21 January 2018

ABIN-2 is required for optimal activation of Erk MAP kinase in innate immune responses

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091271

21 January 2018

Phosphorylation of TPL-2 on serine 400 is essential for lipopolysaccharide activation of extracellular signal-regulated kinase in macrophages

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091271

21 January 2018

Tpl2 (tumor progression locus 2) phosphorylation at Thr290 is induced by lipopolysaccharide via an Ikappa-B Kinase-beta-dependent pathway and is required for Tpl2 activation by external signals

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091271

21 January 2018

Phosphorylation of threonine 290 in the activation loop of Tpl2/Cot is necessary but not sufficient for kinase activity

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091271

21 January 2018

Interleukin-1 stimulated activation of the COT catalytic subunit through the phosphorylation of Thr290 and Ser62.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091271

21 January 2018

Comparative analysis of various in vitro COT kinase assay formats and their applications in inhibitor identification and characterization

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091271

21 January 2018

Design, synthesis, and evaluations of substituted 3-[(3- or 4-carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones as inhibitors of VEGF, FGF, and PDGF receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091271

21 January 2018

IL-1-induced NFkappa B and c-Jun N-terminal kinase (JNK) activation diverge at IL-1 receptor-associated kinase (IRAK)

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091271

21 January 2018

IRAK1: a critical signaling mediator of innate immunity

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091271

21 January 2018

Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091271

21 January 2018

The selectivity of protein kinase inhibitors: a further update

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091271

21 January 2018

Crystal structure of an activated Akt/protein kinase B ternary complex with GSK3-peptide and AMP-PNP

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091271

21 January 2018

Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and toll-like receptor-mediated NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091271

21 January 2018

TPL2-mediated activation of ERK1 and ERK2 regulates the processing of pre-TNF in LPS-stimulated macrophages

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091271

21 January 2018

Identifiers

10.1042/BJ20091271

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39799629&oldid=2111219669"